Grisofulvin 69097-0361-08

Package NDC

69097-0361-08

Manufacturer: Cipla Usa Inc.
Dosage Form: Suspension
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: March 6, 2017
Listing Expires: December 31, 2026
Application: ANDA065354

Need to source Grisofulvin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Griseofulvin	125 mg/5mL

Drug Class

Tubulin Inhibiting Agent [EPC]Decreased Mitosis [PE]Microtubule Inhibition [PE]

Selected Package

69097-0361-08Selected

120 mL in 1 BOTTLE (69097-361-08)